TTBB CAS 124750-51-2 Puritas >96.0% (HPLC)

Description:

Nomen: 5-(4′-Bromomethyl-1,1′-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole

Synonyma: TTBB

CAS: 124750-51-2

Puritas: >96.0% (HPLC)

Aspectus: Alba ad fere alba pulveris

Medium Irbesartanae (CAS: 138402-11-6)

E-Mail: alvin@ruifuchem.com   


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum 5-(4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole
Synonyma TTBB;BBTT;5-[4'-Bromomethyl-(1,1'-Biphenyl)-2-yl]-1-Triphenylmethyltetrazole;N-(Triphenylmethyl) -5-(4'-Bromomethylbiphenyl-2-yl-)tetrazole;Olmesartan Impurity 12;Losartan Bromo N1-Trityl immunditia
CAS Number 124750-51-2
CATTUS Number RF-PI1878
Stock Status In Stock, Productio Capacitas 150MT/Annus
Formulae hypotheticae C33H25BrN4
M. Pondus 557.48
Liquescens punctum 152.0~155.0℃
Density 1.28±0.10 g/cm3
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba ad fere album pulveris
Puritas / Analysis Methodus >96.0% (HPLC)
Damnum in Siccatio <0.50%
immunditiam A <2.00% (HPLC) 5-(4-Methyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole
impudicitia B <2.00% 5-(4'.4'-Dibromomethyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole
Infrared Imaginis Conformat ut Structure
Test Standard Enterprise Standard
Consuetudinem MEDIUS IRBESARTAN (CAS: 138402-11-6).Olmesartan Medoxomil Impuritas

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

1

FAQ:

Applicatio:

5-(4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole (TTBB) (CAS: 124750-51-2) medium est Irbesartan (CAS: 138402-11 -6).Irbesartan adhibetur pro curatione hypertensionis, et nephropathia diabetica cum serum elevatum creatinine et proteinuria (>300 mg/die) in aegris cum diabete speciei et hypertensione.Irbesartan etiam pro secundo agente in curatione conges.Irbesartan est angiotensin II receptor antagonista maxime adhibita ad hypertensionem curationem.Sanofi Investigatio evoluta est (nunc Sanofi-Aventis pars).Communiter venales sunt a Sanofi-Aventis et Bristol-Myers Squibb sub nominibus commercii Aprovel, Karvea et Avapro.

Epistulam tuam hic scribe et mitte nobis